opTricon GmbH
Deal Type
Company sale
Sector
Healthcare
Completion Date
24th October 2018
Deal Value
$5.5m
Company Background
Founded in Berlin in 2005, opTricon Entwicklungsgesellschaft für optische Technologien mbH develops and produces optical system solutions for medical engineering and diagnostics appli-cations. Its product group includes mobile optical analysis devices for point-of-care diagnostics, optical components and systems for signal transmission and optical sensors, and sensors and systems used for measuring and evaluating biological and chemical processes, as well as pro-cess changes. The company’s products are used in such areas as optical data transmission and detection of light signals for medical engineering, bioanalytics, and signal transmission applica-tions.
Deal Summary
Since 2015, Chembio and opTricon have collaborated to develop the DPP® Micro Reader, a hand-held, battery-operated analyzer that uses an innovative image sensor to provide a quan-titative interpretation of diagnostic results when combined with Chembio’s proprietary DPP® tests. Located in Berlin’s Science & Technology Park, opTricon will become Chembio’s Center-of-Excellence for optical technology and serve as Chembio’s European headquarters. As part of its ongoing business, opTricon will continue to develop and manufacture hand-held analyz-ers for OEM customers which do not compete with Chembio.
opTricon GmbH deal contacts
Key members of the Proventis Partners deal team crucial in the opTricon GmbH transaction
Latest Mergers Alliance News
Dresner Partners (USA) advised Connoisseurs Products on its sale to Willert Home Products
Ethica Group (Italy) advised Vicenza Mode, high-end knitwear manufacturer, in the sale of a majority stake to Sienna PE
